Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.
Known by Others names such as osteonecrosis or bone infarction, the condition is gaining global awareness thus supporting the growth of the AVN market. The disease which more commonly afflicts men between the ages of 30 to 50 years, has been highly prevalent in emerging economies.

Market Analysis and Insights: Global Avascular Necrosis Market
The global Avascular Necrosis market size is projected to reach US$ 620.8 million by 2027, from US$ 476.5 million in 2020, at a CAGR of 3.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Avascular Necrosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Avascular Necrosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Avascular Necrosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Avascular Necrosis market.

Global Avascular Necrosis Scope and Market Size
Avascular Necrosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avascular Necrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Trauma Related Avascular Necrosis (AVN)
Non-Trauma Related Avascular Necrosis (AVN)

Segment by Application
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Stryker
Medtronic
Smith and Nephew
Ethicon
Sanofi
Bayer
Pfizer
Merck
Boehringer Ingelheim
Eli Lilly
Aurobindo Pharma
Integra LifeSciences
Zimmer Biomet
Wright Medical
Grifols